BE Receives an Order Worth Rs 895crore from Govt. of India to Supply Liquid Pentavalent Vaccines
Tuesday, March 22, 2016
Biological E. Limited (BE), a Hyderabad, Telangana-based pharmaceutical and vaccine company, has bagged a prestigious tender award for supplying ‘ComBE Five’, a 5-in-1 Liquid Pentavalent Vaccine (LPV), to the Ministry of Health & Family Welfare, Government of India. This vaccine would be inducted into the Government of India’s Universal Immunization Program (UIP) and give a boost to Mission Indradhanush, an initiative to empower the UIP and extend full immunization coverage to at least 90 percent of all children of the country.
The over Rs.895crore order placed on BE to be supplier of ‘ComBE Five’ over a period of two years is a testimony to BE's commitment to preserving health and well-being while adhering to high standards of quality and safety.
Lauding the employees on receiving the award, Mahima Datla, Managing Director, Biological E Limited, said that “It is a momentous occasion for entire BE family! We are proud to be at the forefront of the Universal Immunization Program of India since it aims at saving millions of precious lives of children. In fact, it signals the start of the much awaited countrywide rollout of LPV as part of Mission Indradhanush.”
She also added that, “It is also a historical moment because the ‘Hib’ vaccine is being rolled out all over India. BE has supported the UIP right from its inception as a major vaccine manufacturer. For BE, India is the most significant market and this contract will further contribute to BE’s growth. We are very proud to contribute to the Make in India initiative by becoming one of the world’s largest vaccine manufacturers of Liquid Pentavalent Vaccine.” As part of its expansion in Telangana, BE is investing more than Rs.500crore in building new facilities over a period of 3 years to augment its production capacity for vaccines as well as complex generics. This is expected to generate additional employment for over600 people.
BE's ComBE Five has received World Health Organization’s pre-qualification approval. The vaccine consists of Diphtheria, Tetanus, Pertussis, Hib (Haemophilus Influenza Type b) and Hepatitis B. More than 200million doses of this 5-in-1 vaccine from BE have been administered to children around the world till date. ComBE Five is a 5-in-1, convenient and safe Vaccine that provides effective protection for children from six weeks of age against five deadly diseases: Diphtheria, Tetanus, Pertussis, Hepatitis B and Meningitis and Pneumonia caused by Hib. This vaccine is expected to make a significant contribution to reducing ‘Under 5 Yrs. Mortality’ rates in India.
